TerrAscend (TSNDF) Amortizatization of Intangibles (2021 - 2026)
TerrAscend (TSNDF) reported Amortizatization of Intangibles of $1.8 million for Q1 2026, up 335.29% year-over-year from $408000.0 in Q1 2025, and up 7.25% quarter-over-quarter from $1.7 million in Q4 2025.
TerrAscend (TSNDF) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Amortizatization of Intangibles data on file, last reported at $1.8 million in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $1.8 million, up 335.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (up 32.6% YoY), and the FY2025 annual result was $6.5 million, up 3.88% from the prior year.
- Amortizatization of Intangibles rose to $1.8 million in Q1 2026 per TSNDF's latest filing, from $1.7 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $4.0 million in Q3 2022 and troughed at $408000.0 in Q1 2025.
- A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles sank 58.8% in 2023, then surged 335.29% in 2026.
- A 5-year view of Amortizatization of Intangibles shows it stood at $467000.0 in 2022, then jumped by 227.84% to $1.5 million in 2023, then declined by 0.07% to $1.5 million in 2024, then increased by 8.24% to $1.7 million in 2025, then climbed by 7.25% to $1.8 million in 2026.
- Business Quant data shows TSNDF's Amortizatization of Intangibles at $1.8 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | TerrAscend | - | - | 34.60 Mn | 1.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 408,000.00 |
| Mar 31, 2025 | 408,000.00 |
| Dec 31, 2024 | 1.53 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 716,000.00 |
| Mar 31, 2024 | 716,000.00 |
| Dec 31, 2023 | 1.53 Mn |
| Dec 31, 2023 | 1.53 Mn |